Role of Oxidative Stress in Obese and Nonobese PCOS Patients

Table 1

Demographic and Basic clinical features of the study groups.

	Control group (n = 49)	Nonobese PCOS group (n = 45)	Obese PCOS group (n = 45)	value
Age (year)	23.68 ± 2.2^a	24.12 ± 3.25^a	23.11 ± 2.88^a	0.760
Waist-hip ratio (cm)	0.69 ± 0.05^b	0.074 ± 0.06^b	0.96 ± 0.02^a	0.001
Weight (kg)	66.18 ± 6.6^b	67.2 ± 4.3^b	79.23 ± 3.2^a	0.001
Height (cm)	166.11 ± 5.5^b	164.24 ± 4.65^b	158.2 ± 5.2^a	0.001
BMI (kg/m^2)	23.24 ± 2.2^b	24.34 ± 2.45^b	30.21 ± 1.2^a	0.001
SBP(mmHg)	114.42 ± 12.1^b	112.32 ± 10.21^b	132.2 ± 8.8^a	0.001
DBP (mmHg)	73.21 ± 8.23^b	75.22 ± 7.77^b	84.23 ± 4.4^a	0.001
Menstrual cycle (day)	23.11 ± 4.2^c	54.16 ± 16.6^b	69.44 ± 18.7^a	0.001
FGS	5.32 ± 1.23^c	9.65 ± 2.23^b	12.45 ± 3.67^a	0.001

a: significantly different from the obese PCOS group and the nonobese PCOS group ( < 0.05). b: significantly different from the obese PCOS group and controls ( < 0.05). c: significantly different from the nonobese PCOS group and controls ( < 0.05). Values are expressed as mean ± SD. Statistical significance was defined as  < 0.05. FGS: Ferriman–Gallwey score.